SPDR S&P Biotech ETF
700 hedge funds and large institutions have $6.42B invested in SPDR S&P Biotech ETF in 2022 Q3 according to their latest regulatory filings, with 100 funds opening new positions, 218 increasing their positions, 223 reducing their positions, and 93 closing their positions.
Holders
700
Holders Change
-2
Holders Change %
-0.28%
% of All Funds
12.1%
Holding in Top 10
33
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.13%
% of All Funds
0.57%
New
100
Increased
218
Reduced
223
Closed
93
Calls
$1.99B
Puts
$1.9B
Net Calls
+$89M
Net Calls Change
+$62.3M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$201M |
| 2 |
2
Two Sigma Advisers
New York
|
$105M |
| 3 |
3
Janus Henderson Group
London,
United Kingdom
|
$79.2M |
| 4 |
4
Brown Advisory
Baltimore,
Maryland
|
$77M |
| 5 |
5
Two Sigma Investments
New York
|
$52.6M |
